<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58258">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02347605</url>
  </required_header>
  <id_info>
    <org_study_id>WS2385492</org_study_id>
    <nct_id>NCT02347605</nct_id>
  </id_info>
  <brief_title>Medicinal Nicotine for Preventing Cue Induced Craving</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if changing the timeframe (relative to cue
      presentation) at which the nicotine lozenge is given can attenuate the increase in symptoms
      of tobacco craving and withdrawal that occur when smokers are presented with smoking cues.
      In this cross-over study, all subjects attend three laboratory sessions at which either
      nicotine lozenge or placebo is given prior to presentation of smoking cues or after
      presentation of smoking cues. The order in which the three conditions will be presented are
      randomized.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Craving symptom severity score assessed via questionnaire</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>The craving increase that occurs when smokers are exposed to smoking cues will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Withdrawal symptom severity score assessed via questionnaire</measure>
    <time_frame>up to 1 hour</time_frame>
    <description>The withdrawal symptom increase that occurs when smokers are exposed to smoking cues will be measured</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Nicotine lozenge prior to cue exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nicotine lozenge is used 15 minutes prior to smoking cue exposure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo lozenge prior to cue exposure</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo lozenge is used 15 minutes prior to smoking cue exposure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control condition: Lozenge after cue exposure</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Lozenge is used immediately after smoking cue exposure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine lozenge 4 mg</intervention_name>
    <arm_group_label>Nicotine lozenge prior to cue exposure</arm_group_label>
    <arm_group_label>Control condition: Lozenge after cue exposure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo lozenge</intervention_name>
    <arm_group_label>Placebo lozenge prior to cue exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Smoking a minimum number of cigarettes per day

          -  General good health

        Exclusion Criteria:

          -  unstable medical or psychiatric conditions

          -  history of severe motion sickness (due to virtual reality equipment used to present
             cues)

          -  women who are pregnant or breast feeding

        The investigators will evaluate if there are other reasons why someone may not participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kotlyar, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical and Translational Sciences Institute</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <lastchanged_date>September 25, 2015</lastchanged_date>
  <firstreceived_date>January 14, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
